Antisense oligonucleotides against protein kinase CK2-α inhibit growth of squamous cell carcinoma of the head and neck in vitro

Head and Neck

Volumn 22, Issue 4, 2000, Pages 341-346

  Faust, Russell A ^a,b,c,d   Tawfic, Sherif ^b,c   Davis, Alan T ^c   Bubash, Lori A ^a   Ahmed, Khalil ^b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

Chromatin; Gene therapy; Kinase; Nuclear matrix; Oncogene; Oncoprotein; Prognostic marker

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASEIN KINASE II;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE TARGETING; GENETIC TRANSFECTION; GROWTH INHIBITION; HEAD CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; NECK CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CASEIN KINASE II; CELL DIVISION; CODON, NONSENSE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION; GINGIVAL NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PROBABILITY; PROTEIN-SERINE-THREONINE KINASES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034096356     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0347(200007)22:4<341::AID-HED5>3.0.CO;2-3     Document Type: Article

References (28)

1. Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992;70:375-387.
2. Pelech SL, Sanghera JS, Daya-Makin M. Protein kinase cascades in meiotic and mitotic cell cycle control. Biochem Cell Biol 1990;68:1297-1330.
3. Cantley LC, Auger KR, Carpenter C, et al. Oncogenes and signal transduction. Cell 1991;64:281-302.
4. Hunter T. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 1995; 80:225-236.
5. Edelman AM, Blumenthal DK, Krebs EG. Protein serine/ threonine kinases. Ann Rev Biochem 1987;56:567-613.
6. Issinger O-G. Casein kinases: Pleiotropic mediators of cellular regulation. Pharmacol Ther 1993;59:1-30.
7. Masliah E, Iimoto DS, Mallory M, Albright T, Hansen L, Tsunao S. Casein kinase II alteration precedes tau accumulation in tangle formation. Am J Pathol 1992;140: 263-268.
8. Ahmed K. Significance of the casein kinase system in cell growth and proliferation with emphasis on studies of the androgenic regulation of the prostate. Cell Mol Biol Res 1994;40:1-11.
9. Munstermann U, Fritz G, Seitz G, Yiping L, Schneider HR, Issinger O-G. Casein kinase II is elevated in solid human tumors and rapidly proliferating non-neoplastic tissues. Eur J Biochem 1990;189:251-257.
10. Daya-Makin M, Sanghera JS, Mogentale TL, et al. Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung. Cancer Res 1994;54: 2262-2269.
11. Faust RA, Gapany M, Tristani-Firouzi P, Davis AT, Adams GL, Ahmed A. Elevated protein kinase CK2 activity in chromatin of head and neck tumors: Association with malignant transformation. Cancer Lett 1996;101:31-35.
12. Gapany M, Faust RA, Tawfic S, Davis A, Ahmed K. Association of protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck. Molec Med 1995;1:659-666.
13. Ahmed K, Davis A, Hanten J, Lambert D, McIvor S, Goueli S. Cloning of a rat cDNA for alpha and beta subunits of casein kinase 2 (CK-2): Investigation of molecular regulation of CK-2 by androgens in rat ventral prostate. Cell Mol Biol Res 1993;39:451-462.
14. # and the A*′ subunits of casein kinase II. Biochemistry 1990;29:8436-8447.
15. Schalasta G, Doppler C. Inhibition of c-fos transcription and phosphorylation of the serum response factor by an inhibitor of phospholipase C-type reactions. Mol Cell Biol 1990;10:5558-5561.
16. Faust RA, Tawfic S, Davis AT, Ahmed K. Apoptosis and growth inhibition of head and neck tumor cell line induced by epidermal growth factor receptor tyrosine kinase inhibitor. Eur J Cancer (Oral Oncology) 1999;35: 290-295.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-254.
18. Zar JH. Biostatistical analysis. Englewood Cliffs, NJ: Prentice Hall; 1984.
19. Stein, CA, Cheng Y-C. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science 1993;261:1004-1012.
20. Mercola D, Cohen JS. Antisense approaches to cancer gene therapy. Cancer Gene Ther 1995;2:47-59.
21. Stein CA, Cohen JS. Oligodeoxynucleotides as inhibitors of gene expression: A review. Cancer Res 1988;48: 2659-2668.
22. Ulloa L, Diaz-Nido J, Avila J. Depletion of catalytic and regulatory subunits of protein kinase CK2 by antisense oligonucleotide treatment of neuroblastoma cells. Cell Mol Neurobiol 1994;14:407-414.
23. Pepperkok R, Lorenz P, Jakobi R, Ansorge W, Pyerin W. Cell growth stimulation by EGF: Inhibition through antisense-oligodeoxynucleotides demonstrates important role of casein kinase II. Exp Cell Res 1991;197:245-253.
24. Bousset K, Henriksson M, Luscher-Firzlaff JM, Litchfield DW, Luscher B. Identification of casein kiase II phosphorylation sites in Max: Effects of DNA-binding kinetics of max homo-O and Myc/max heterodimers. Oncogene 1993; 8:3211-3220.
25. Tawfic S, Davis AT, Faust RA, Gapany G, Ahmed K. Modulation of nuclear matrix protein phosphorylation by histones: Possible involvement of nuclear matrix-associated protein kinase CK2 activity. J Cell Biochem 1999;72:242-250.
26. Tawfic S, Faust RA, Gapany M, Ahmed K. Nuclear matrix as an anchor for protein kinase CK2 nuclear signaling. J Cell Biochem 1996;62:161-171.
27. Guo C, Davis AT, Ahmed K. Dynamics of protein kinase CK2 association with nucleosomes in relation to transcriptional activity. J Biol Chem 1998;273:13675-13680.
28. Seldin DC, Leder P. Casein kinase IIα transgene-induced murine lymphoma: Relation to theileroiosis in cattle. Science 1995;267:894-897.